WestHill Financial Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-359
Closed -$277K 78
2024
Q4
$277K Sell
359
-10
-3% -$8.28K 0.06% 58
2024
Q3
$327K Sell
369
-20
-5% -$18K 0.07% 56
2024
Q2
$352K Sell
389
-7
-2% -$5.6K 0.09% 49
2024
Q1
$308K Sell
396
-80
-17% -$56.9K 0.08% 56
2023
Q4
$277K Sell
476
-2
-0.4% -$1.17K 0.07% 56
2023
Q3
$257K Sell
478
-19
-4% -$9.79K 0.07% 51
2023
Q2
$233K Buy
+497
New +$208K 0.07% 56
2023
Q1
Sell
-549
Closed -$201K 121
2022
Q4
$201K Buy
+549
New +$195K 0.06% 62

Other funds holding LLY

WestHill Financial Advisors's LLY Position: Q1 2025 in Review

WestHill Financial Advisors sold out of Eli Lilly (LLY) in Q1 2025, closing a stake of 359 shares — an estimated $277K sold.

WestHill Financial Advisors first reported a position in LLY in Q4 2022 and held it in 8 quarters. The position peaked at $352K in Q2 2024. 3,919 funds tracked by Wall St. Rank hold LLY as of Q1 2025.

  • WestHill Financial Advisors reported no remaining Eli Lilly position as of Q1 2025 after selling out during the quarter.
  • WestHill Financial Advisors sold 359 Eli Lilly shares in Q1 2025, an estimated $277K.
  • WestHill Financial Advisors first reported a position in Eli Lilly in Q4 2022 and held it in 8 quarters.
  • WestHill Financial Advisors's Eli Lilly position peaked at $352K in Q2 2024.
  • 3,919 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2025.

Based on WestHill Financial Advisors's 13F filing for Q1 2025, filed 21 Apr 2025.